Clinic
Ben Archer Health Center
Ben Archer Health Center was paid $84.14M by Medicaid between Jan 2018 and Nov 2024, across 231 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoBEN ARCHER HEALTH CENTER
HATCH, NM 87937
HATCH, NM 87937
33aNPI1154352532assigned 07/05/2006
33bProvider typeClinic/Center
28Total paid$84.14M
24GClaims871,499
24DCodes billed231
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinic/Center providers in New Mexico
Rank by total paid#1 of 52
Median peer was paid$827K
This provider vs. median102×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 129,004 | $14.36M | |
| 2019 | 109,963 | $11.51M | |
| 2020 | 129,635 | $10.85M | |
| 2021 | 165,967 | $14.54M | |
| 2022 | 136,549 | $13.13M | |
| 2023 | 114,573 | $11.18M | |
| 2024incomplete | 85,808 | $8.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 206,449 | 179,327 | $37.53M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14% | 70,259 | 62,523 | $12.02M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 7.2% | 33,302 | 23,837 | $6.03M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 4.9% | 22,375 | 14,943 | $4.11M |
| D0999 | Unspecified diagnostic procedure, by report | 3.9% | 17,302 | 14,097 | $3.29M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 19,073 | 18,260 | $3.25M |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 2.1% | 15,741 | 15,314 | $1.77M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.9% | 8,234 | 8,208 | $1.56M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.5% | 6,926 | 4,804 | $1.26M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.5% | 6,273 | 6,238 | $1.24M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 5,857 | 5,685 | $1.16M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.3% | 5,402 | 5,377 | $1.05M |
219 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 5,257 | $1.04M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.2% | 4,997 | $984K |
| G0467 | Community health center visit, returning patient | 1.2% | 23,718 | $970K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 4,605 | $915K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,985 | $785K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 3,357 | $648K |
| 99441 | <1% | 15,262 | $416K | |
| Q3014 | Telehealth originating site facility fee | <1% | 27,791 | $350K |
| 99442 | <1% | 8,042 | $348K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,737 | $319K |
| 99385 | <1% | 1,460 | $292K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,347 | $252K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,197 | $228K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,263 | $224K |
| 90863 | <1% | 1,273 | $145K | |
| 99386 | <1% | 607 | $121K | |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 3,365 | $121K |
| 99381 | <1% | 560 | $111K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 581 | $110K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16,219 | $109K |
| 99384 | <1% | 485 | $96K | |
| 99223 | Prolong inpt eval add15 m | <1% | 465 | $93K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,738 | $85K |
| 99383 | <1% | 421 | $82K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 408 | $82K |
| 93000 | <1% | 2,641 | $63K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 3,933 | $61K |
| 99422 | <1% | 1,890 | $51K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 239 | $46K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,571 | $44K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 11,029 | $41K |
| 99173 | <1% | 4,139 | $38K | |
| 90686 | <1% | 6,215 | $37K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 454 | $36K |
| 69210 | <1% | 1,087 | $29K | |
| 99382 | <1% | 150 | $28K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12,545 | $28K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,852 | $28K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,149 | $27K |
| 72100 | <1% | 957 | $25K | |
| 90899 | <1% | 134 | $25K | |
| 99421 | <1% | 2,589 | $23K | |
| 73562 | <1% | 971 | $22K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,855 | $22K |
| 92551 | <1% | 1,665 | $22K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 116 | $19K |
| 96150 | <1% | 73 | $14K | |
| 90715 | <1% | 1,914 | $13K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,171 | $13K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 295 | $13K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 1,478 | $12K |
| 99443 | <1% | 221 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18,425 | $11K |
| 99205 | Prolong outpt/office vis | <1% | 43 | $8K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,362 | $7K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,149 | $7K |
| 73630 | <1% | 341 | $7K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 428 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,242 | $7K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 55 | $6K |
| 73030 | <1% | 213 | $5K | |
| 99220 | <1% | 25 | $5K | |
| 81002 | <1% | 1,787 | $4K | |
| 74018 | <1% | 213 | $4K | |
| 87807 | <1% | 555 | $4K | |
| 36416 | <1% | 1,022 | $4K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,638 | $4K |
| 85610 | <1% | 509 | $3K | |
| 73610 | <1% | 160 | $3K | |
| 99423 | <1% | 64 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 920 | $3K |
| 83655 | <1% | 588 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 94 | $2K |
| 96103 | <1% | 12 | $2K | |
| 73110 | <1% | 85 | $2K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 166 | $2K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 44 | $2K |
| 90658 | <1% | 416 | $2K | |
| 99217 | <1% | 12 | $2K | |
| 91301 | <1% | 5,059 | $2K | |
| G0466 | Community health center visit, new patient | <1% | 40 | $2K |
| 73130 | <1% | 95 | $1K | |
| 85014 | <1% | 1,736 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,460 | $1K |
| 87428 | <1% | 1,191 | $1K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 17 | $1K |
| 1000F | <1% | 14,487 | $924.93 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 120 | $701.66 |
| 81025 | <1% | 7,180 | $696.57 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 121 | $639.41 |
| 3351F | <1% | 13,810 | $630.72 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 443 | $583.37 |
| 82270 | <1% | 248 | $581.70 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 475 | $559.76 |
| 86580 | <1% | 180 | $558.64 | |
| 3008F | <1% | 8,225 | $514.52 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 157 | $513.90 |
| 0011A | <1% | 2,143 | $481.75 | |
| 84481 | <1% | 52 | $468.64 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 43 | $463.79 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,492 | $435.75 |
| 72040 | <1% | 12 | $416.54 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 17 | $400.79 |
| 90734 | <1% | 1,255 | $338.81 | |
| 72070 | <1% | 13 | $337.56 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 41 | $333.74 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 522 | $324.20 |
| 90732 | <1% | 593 | $319.58 | |
| 1036F | <1% | 6,419 | $287.53 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,416 | $241.66 |
| 80053 | Comprehensive metabolic panel | <1% | 11,280 | $227.18 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,178 | $200.49 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 323 | $198.22 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 10,307 | $196.47 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,265 | $165.27 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,454 | $163.63 |
| 91303 | <1% | 281 | $159.39 | |
| 86677 | <1% | 15 | $153.84 | |
| 94200 | <1% | 45 | $146.34 | |
| 86592 | <1% | 1,171 | $124.84 | |
| 81003 | <1% | 10,001 | $115.17 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 26 | $94.80 |
| 0013A | <1% | 547 | $93.42 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 15 | $85.39 |
| 90723 | <1% | 949 | $77.16 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,549 | $74.44 |
| 82948 | <1% | 1,991 | $68.83 | |
| 4004F | <1% | 3,237 | $66.13 | |
| 80061 | Lipid panel | <1% | 7,505 | $56.68 |
| 90707 | <1% | 42 | $53.49 | |
| 99406 | <1% | 71 | $50.40 | |
| 87480 | <1% | 526 | $46.20 | |
| 87070 | <1% | 1,899 | $44.23 | |
| 82607 | <1% | 1,569 | $43.39 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 14 | $32.70 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 55 | $31.61 |
| 90670 | <1% | 2,072 | $6.66 | |
| 90651 | <1% | 1,782 | $4.85 | |
| 90633 | <1% | 1,468 | $4.60 | |
| 90710 | <1% | 1,006 | $3.14 | |
| 3078F | <1% | 1,122 | $2.16 | |
| 3074F | <1% | 1,183 | $2.15 | |
| 0012A | <1% | 2,157 | $1.98 | |
| 90680 | <1% | 628 | $1.92 | |
| 90647 | <1% | 430 | $1.72 | |
| 90648 | <1% | 550 | $1.72 | |
| 90700 | <1% | 236 | $0.79 | |
| 90698 | <1% | 299 | $0.68 | |
| 3079F | <1% | 335 | $0.62 | |
| 3044F | <1% | 114 | $0.36 | |
| 3075F | <1% | 162 | $0.31 | |
| 0031A | <1% | 284 | $0.19 | |
| 90660 | <1% | 60 | $0.14 | |
| 3077F | <1% | 58 | $0.12 | |
| 3051F | <1% | 25 | $0.10 | |
| 90716 | <1% | 55 | $0.08 | |
| 3080F | <1% | 14 | $0.03 | |
| 3046F | <1% | 12 | $0.03 | |
| 90681 | <1% | 13 | $0.02 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 8,563 | $0.00 |
| 81001 | 0% | 3,828 | $0.00 | |
| 88142 | 0% | 1,659 | $0.00 | |
| 84480 | 0% | 833 | $0.00 | |
| 84436 | 0% | 1,725 | $0.00 | |
| 84479 | 0% | 745 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 3,747 | $0.00 |
| 82728 | 0% | 866 | $0.00 | |
| 90696 | 0% | 505 | $0.00 | |
| 82746 | 0% | 1,129 | $0.00 | |
| 86803 | 0% | 1,351 | $0.00 | |
| 85652 | 0% | 259 | $0.00 | |
| 0513F | 0% | 478 | $0.00 | |
| 1034F | 0% | 27 | $0.00 | |
| 82043 | 0% | 3,236 | $0.00 | |
| 85018 | 0% | 419 | $0.00 | |
| 87510 | 0% | 527 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 206 | $0.00 |
| 90619 | 0% | 98 | $0.00 | |
| 86701 | 0% | 62 | $0.00 | |
| 86140 | 0% | 101 | $0.00 | |
| 83550 | 0% | 133 | $0.00 | |
| 90677 | 0% | 76 | $0.00 | |
| D1330 | 0% | 517 | $0.00 | |
| 87081 | 0% | 38 | $0.00 | |
| 86710 | 0% | 184 | $0.00 | |
| 0134A | 0% | 38 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 44 | $0.00 |
| 90620 | 0% | 61 | $0.00 | |
| 82044 | 0% | 41 | $0.00 | |
| 0064A | 0% | 32 | $0.00 | |
| 84153 | 0% | 61 | $0.00 | |
| 90674 | 0% | 37 | $0.00 | |
| D0272 | Bitewings - two radiographic images | 0% | 13 | $0.00 |
| 83735 | 0% | 14 | $0.00 | |
| 87660 | 0% | 553 | $0.00 | |
| D1110 | Prophylaxis - adult | 0% | 305 | $0.00 |
| 83540 | 0% | 871 | $0.00 | |
| 82570 | 0% | 2,091 | $0.00 | |
| 84439 | 0% | 1,350 | $0.00 | |
| D1120 | Dental cleaning, child | 0% | 219 | $0.00 |
| 90461 | 0% | 6,502 | $0.00 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 0% | 566 | $0.00 |
| 87075 | 0% | 1,084 | $0.00 | |
| 90685 | 0% | 978 | $0.00 | |
| 80074 | 0% | 985 | $0.00 | |
| 86038 | 0% | 218 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 0% | 22 | $0.00 |
| 87210 | 0% | 12 | $0.00 | |
| 90671 | 0% | 12 | $0.00 | |
| 84403 | 0% | 51 | $0.00 | |
| D0274 | Bitewings - four radiographic images | 0% | 77 | $0.00 |
| 91313 | 0% | 59 | $0.00 | |
| 86431 | 0% | 36 | $0.00 | |
| 90756 | 0% | 61 | $0.00 | |
| D1999 | 0% | 40 | $0.00 | |
| 90621 | 0% | 33 | $0.00 | |
| 1033F | 0% | 16 | $0.00 | |
| D0330 | Panoramic radiographic image | 0% | 15 | $0.00 |
| 84146 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROOKER, MARY (FISCAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Ben Archer Health Center | Las Cruces, NM | $2.17M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.